Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/306% below fair value
$3.41−0.04 (-1.16%)
Close on Nov 12, 2026Market cap $1.26BP/E 20.1Yield –
Cronos enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cronos's enterprise value was $530.76M on Nov 11, 2026, against $171.12M a year earlier. Over the last 5 years it ranged from -$172.93M to $530.76M, with a median of $117.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $530.76M | +128.4% |
| 2025 | Dec 31, 2025 | $232.38M | – |
| 2024 | Dec 31, 2024 | -$40.05M | – |
| 2023 | Dec 29, 2023 | -$46.09M | -166.5% |
| 2022 | Dec 30, 2022 | $69.35M | -83.5% |
| 2021 | Dec 31, 2021 | $420.59M | -66.2% |
| 2020 | Dec 31, 2020 | $1.24B | -64.2% |
| 2019 | Jan 31, 2019 | $3.47B | +89.8% |
| 2018 | Dec 31, 2018 | $1.83B | +203.8% |
| 2017 | Dec 29, 2017 | $602.22M | – |
See a number that looks wrong?